Spero R. Cataland

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Major adverse cardiovascular events in survivors of immune‐mediated thrombotic thrombocytopenic purpura”.

Major adverse cardiovascular events in survivors of immune‐mediated thrombotic thrombocytopenic purpura

American Journal of Hematology(2021)10.1002/ajh.26341

N/A

0DataRank · unranked

34 citations

Senthil Sukumar, Sruthi Selvakumar, Lisa R. Yanek, Sarah Hussain, Marshall Mazepa +7 more

Race, rituximab, and relapse in TTP

Blood(2022)10.1182/blood.2022016640

N/A

0DataRank · unranked

41 citations

Ana G. Antun, Andrew M. Farland, Ryan Woods, Ara Metjian, Yara A. Park +24 more

Health following recovery from immune thrombotic thrombocytopenic purpura: the patient’s perspective

Blood Advances(2022)10.1182/bloodadvances.2022008342

N/A

0DataRank · unranked

10 citations

Marshall K. Cheney, Clare M. Martin, Spero R. Cataland, Lauren B. Quick, San Keller +7 more

A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry

Blood Advances(2023)10.1182/bloodadvances.2023010807

N/A

0DataRank · unranked

7 citations

Chong Zhang, Angela P. Presson, Shruti Chaturvedi, Ana G. Antun, Andrew M. Farland +26 more

A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura

Research and Practice in Thrombosis and Haemostasis(2024)10.1016/j.rpth.2024.102388

N/A

0DataRank · unranked

6 citations

Chong Zhang, Angela P. Presson, Shruti Chaturvedi, Ana G. Antun, Andrew M. Farland +26 more

Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era

Blood Advances(2024)10.1182/bloodadvances.2024013313

N/A

0DataRank · unranked

4 citations

Michael D. Evans, Jenna Brown, Elizabeth E. Davis, Andrew D. Johnson, Ana G. Antun +27 more

A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura

UNC Libraries(2024)10.17615/djvv-pg14

N/A

0DataRank · unranked

0 citations

Harsh Vardhan Upreti, X. Long Zheng, Jay S. Raval, Raj S. Kasthuri, Spero R. Cataland +27 more

Relapse Free Survival Progressive Shortens in a Subset of Black patients with Immune TTP Treated in the Rituximab Era

UNC Libraries(2024)10.17615/pf72-y335

N/A

0DataRank · unranked

0 citations

Camila Masias, Michael D. Evans, Shruti Chaturvedi, Ryan Woods, Yara A. Park +28 more

Multicenter Prospective Pilot Study Identifying Thrombomodulin as a Potential Biomarker for Neurocognitive Outcomes in Immune Thrombotic Thrombocytopenic Purpura

Journal of Clinical Medicine(2025)10.3390/jcm14030694

N/A

0DataRank · unranked

4 citations

Michael D. Evans, Shangbin Yang, Senthil Sukumar, James G. Scott, Deirdra R. Terrell +3 more

Alemtuzumab in frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study

Cancer(2025)10.1002/cncr.35750

N/A

0DataRank · unranked

3 citations

Jun Yin, Gerard Lozanski, Emily Curran, Gregory Malnassy, Krzysztof Mrózek +15 more